Prognostic Significance of Serum S100B Protein in High-Risk Surgically Resected Melanoma Patients Participating in Intergroup Trial ECOG 1694

PURPOSE: We evaluated adjuvant trial E1694 to more precisely define the prognostic significance of serum S100B in patients with high-risk resected melanoma. PATIENTS AND METHODS: Sera from 670 E1694 patients banked at baseline and three additional time points were tested for S100B protein using chem...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Tarhini, Ahmad A., Stuckert, Joseph, Lee, Sandra, Sander, Cindy, Kirkwood, John M.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2009
Assuntos:
Melanoma
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3426933/
https://ncbi.nlm.nih.gov/pubmed/19047287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.17.1777
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares